Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 3;11:778774. doi: 10.3389/fonc.2021.778774

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Liao, Zhang, Yang, Liu, Yang, Li, Xing, Teng, Yang, Zhao, Zhao, Bai, Zhu and Yang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Comparison of the mPFS and mOS between the Endostar combined chemotherapy group and chemotherapy group. (A) Comparison of the mPFS in the entire cohort. (B) Comparison of the mOS in the entire cohort. (C) Comparison of the mPFS in patients with osteogenic sarcoma. (D) Comparison of the mOS in patients with osteogenic sarcoma. (E) Comparison of the mPFS in patients with soft tissue sarcoma. (F) Comparison of the mOS in patients with soft tissue sarcoma. (G) Comparison of the mPFS in patients with UPS. (H) Comparison of the mOS in patients with UPS. (I) Comparison of the mPFS in patients with non-UPS. (J) Comparison of the mOS in patients with non-UPS.